Burnie Academy
Mounjaro (tirzepatide): what Indians should know

Mounjaro (tirzepatide): what Indians should know

Mounjaro is the brand name for tirzepatide, a weekly injection that acts on two gut-hormone pathways (GLP-1 and GIP) to cut appetite and blood sugar. The US FDA approved Mounjaro for type-2 diabetes and a second brand, Zepbound, for chronic weight management. Trials show more weight loss than semaglutide on average, but also more side-effect risk. This article tells you honestly what it does, what can go wrong, and why the dose and the decision must come from your doctor, not from a WhatsApp forward or an informal seller.

13 Jul 2026 · Burnie Academy
tirzepatide glp1 weight-loss-medicine mounjaro

You have heard the name in a group chat, on a reel, or from a friend who 'lost 8 kilos'. Mounjaro. The buzz is real, but the buzz skips the important parts: who it is for, what it does in your body, and what can go wrong. Mounjaro is a brand of a medicine called tirzepatide. It is a once-a-week injection given under the skin. The same medicine, under the brand Zepbound, is approved in the US for weight management. In India many people try to buy it informally, without a doctor. That is risky. This article tells you what tirzepatide is, how it works, the honest side-effect list, and why the dose and the decision must come from your doctor. Stronger does not automatically mean safer, and 'new' does not automatically mean 'right for you'.

CONTINUE READING FOR FREE

Unlock the complete article

Register with just your mobile number and OTP. No password and no payment.

Use this same phone number in the Burnie mobile app. Your profile, liked articles and favourites will stay synced.

By continuing, you agree to Burnie's Terms and Privacy Policy.

Track your food the honest way

Burnie helps you see your estimated calorie deficit with familiar Indian foods — no fake precision, no guilt trips.

Get Burnie on the App Store

Sign in with the same mobile number you use for Academy. Android public availability is being expanded.